EMAIL THIS PAGE TO A FRIEND

Mucosal immunology

Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon.


PMID 25005358

Abstract

The delivery of luminal substances across the intestinal epithelium to the immune system is a critical event in immune surveillance, resulting in tolerance to dietary antigens and immunity to pathogens. How this process is regulated is largely unknown. Recently goblet cell-associated antigen passages (GAPs) were identified as a pathway delivering luminal antigens to underlying lamina propria (LP) dendritic cells in the steady state. Here, we demonstrate that goblet cells (GCs) form GAPs in response to acetylcholine (ACh) acting on muscarinic ACh receptor 4. GAP formation in the small intestine was regulated at the level of ACh production, as GCs rapidly formed GAPs in response to ACh analogs. In contrast, colonic GAP formation was regulated at the level of GC responsiveness to ACh. Myd88-dependent microbial sensing by colonic GCs inhibited the ability of colonic GCs to respond to Ach to form GAPs and deliver luminal antigens to colonic LP-antigen-presenting cells (APCs). Disruption of GC microbial sensing in the setting of an intact gut microbiota opened colonic GAPs, and resulted in recruitment of neutrophils and APCs and production of inflammatory cytokines. Thus GC intrinsic sensing of the microbiota has a critical role regulating the exposure of the colonic immune system to luminal substances.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SML0255
4-DAMP, ≥98% (HPLC)
C21H26INO2
A0132
Atropine, ≥99% (TLC), powder
C17H23NO3
37019
Atropine, analytical standard
C17H23NO3
Y0000878
Atropine, European Pharmacopoeia (EP) Reference Standard
C17H23NO3
Y0000845
Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard
C17H23NO3
M3761
Metronidazole, analytical standard
C6H9N3O3
M1547
Metronidazole, BioXtra
C6H9N3O3
46461
Metronidazole, VETRANAL, analytical standard
C6H9N3O3
M1850000
Metronidazole, European Pharmacopoeia (EP) Reference Standard
C6H9N3O3
PHR1052
Metronidazole, Pharmaceutical Secondary Standard; Certified Reference Material
C6H9N3O3
M8046
Mifepristone, ≥98%
C29H35NO2
P1636
Phenobarbital
C12H12N2O3
P-008
Phenobarbital solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material
C12H12N2O3
411027
Piperidine, ≥99.5%, purified by redistillation
C5H11N
571261
Piperidine, biotech. grade, ≥99.5%
C5H11N
80640
Piperidine, puriss. p.a., ≥99.0% (GC/T)
C5H11N
104094
Piperidine, ReagentPlus®, 99%
C5H11N
76046
Piperidine, analytical standard
C5H11N
80642
Piperidine, purum, ≥96.0% (GC/T)
C5H11N
W290807
Piperidine, ≥99%, FCC
C5H11N
80645
Piperidine solution, for peptide synthesis, 20% in DMF
C5H11N
T9778
Tropicamide, solid
C17H20N2O2
T2580000
Tropicamide, European Pharmacopoeia (EP) Reference Standard
C17H20N2O2